Related Experiment Video
Updated: Jul 20, 2025

Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis
Published on: April 25, 2025
Kidney fibrosis: Emerging diagnostic and therapeutic strategies
Barbara Mara Klinkhammer1, Peter Boor2
1Institute of Pathology, RWTH Aachen University Hospital, Aachen, Germany.
Abstract:
An increasing number of patients worldwide suffers from chronic kidney disease (CKD). CKD is accompanied by kidney fibrosis, which affects all compartments of the kidney, i.e., the glomeruli, tubulointerstitium, and vasculature. Fibrosis is the best predictor of progression of kidney diseases. Currently, there is no specific anti-fibrotic therapy for kidney patients and invasive renal biopsy remains the only option for specific detection and quantification of kidney fibrosis. Here we review emerging diagnostic approaches and potential therapeutic options for fibrosis. We discuss how translational research could help to establish fibrosis-specific endpoints for clinical trials, leading to improved patient stratification and potentially companion diagnostics, and facilitating and optimizing development of novel anti-fibrotic therapies for kidney patients.
Insights
Chronic kidney disease (CKD) involves kidney fibrosis, a key progression predictor. This review explores new diagnostic tools and therapies to combat fibrosis and improve patient outcomes.
Area of Science:
- Nephrology
- Pathology
- Translational Medicine
Background:
- Chronic kidney disease (CKD) affects millions globally, characterized by progressive kidney fibrosis.
- Kidney fibrosis impacts glomeruli, tubulointerstitium, and vasculature, serving as a primary indicator of disease progression.
- Current management lacks specific anti-fibrotic treatments, and diagnosis relies on invasive renal biopsies.
Purpose of the Study:
- To review emerging diagnostic strategies for kidney fibrosis.
- To explore potential therapeutic interventions for renal fibrosis.
- To discuss the role of translational research in developing anti-fibrotic therapies and companion diagnostics for CKD.
Main Methods:
- Literature review of current research on kidney fibrosis diagnostics and therapeutics.
- Analysis of translational research findings relevant to clinical applications.
- Discussion of clinical trial endpoint development for anti-fibrotic drug evaluation.
Main Results:
- Emerging diagnostic approaches offer non-invasive alternatives for fibrosis detection and quantification.
- Several therapeutic strategies are under investigation for targeting kidney fibrosis.
- Translational research is crucial for validating new endpoints and facilitating drug development.
Conclusions:
- Novel diagnostic and therapeutic strategies are needed to address kidney fibrosis in CKD.
- Advancements in translational research can accelerate the development of effective anti-fibrotic treatments.
- Improved patient stratification and companion diagnostics will optimize the management of kidney fibrosis.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease I: Introduction
Acute Kidney Injury V: Interprofessional Care
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management

